Molecular Characterization and Antimicrobial Susceptibility of Biofilm-forming Acinetobacter baumannii Clinical Isolates from Daejeon, Korea
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The emergence and dissemination of multidrug-resistant (MDR) Acinetobacter baumannii isolates have been reported worldwide, with most of these possessing the ability to form biofilms. Biofilm formation is an important virulence factor associated with the resistance to disinfection and desiccation. This study examined the genetic basis of antimicrobial resistance mechanisms of biofilm-forming A. baumannii clinical isolates. Imaging and quantification of biofilms were performed by a crystal violet assay and 46 biofilm-forming A. baumannii isolates were selected. Subsequently, 16 isolates belonging to different clones were identified using REP-PCR, and detection of the antimicrobial determinants in the isolates was carried out. The 16 isolates included 9 non-MDR and 7 MDR isolates. The mean biomass OD560 values of the non-MDR (0.96) and MDR (1.05) isolates differed but this difference was not significant. In this study, most biofilm-forming MDR A. baumannii isolates contained various antimicrobial resistance determinants (blaOXA-23, armA, and mutations of gyrA and parC). On the other hand, most biofilm-forming non-MDR A. baumannii isolates did not contain antimicrobial resistance determinants. These results suggest that there is little correlation between the biofilm-forming ability and antimicrobial susceptibility in A. baumannii isolates. In addition, the emergence of MDR A. baumannii clinical isolates is generally caused by mutations of the genes associated with antimicrobial resistance and/or the acquisition of various antimicrobial resistance determinants.
Abstract
The emergence and dissemination of multidrug-resistant (MDR) Acinetobacter baumannii isolates have been reported worldwide, with most of these possessing the ability to form biofilms. Biofilm formation is an important virulence factor associated with the resistance to disinfection and desiccation. This study examined the genetic basis of antimicrobial resistance mechanisms of biofilm-forming A. baumannii clinical isolates. Imaging and quantification of biofilms were performed by a crystal violet assay and 46 biofilm-forming A. baumannii isolates were selected. Subsequently, 16 isolates belonging to different clones were identified using REP-PCR, and detection of the antimicrobial determinants in the isolates was carried out. The 16 isolates included 9 non-MDR and 7 MDR isolates. The mean biomass OD560 values of the non-MDR (0.96) and MDR (1.05) isolates differed but this difference was not significant. In this study, most biofilm-forming MDR A. baumannii isolates contained various antimicrobial resistance determinants (blaOXA-23, armA, and mutations of gyrA and parC). On the other hand, most biofilm-forming non-MDR A. baumannii isolates did not contain antimicrobial resistance determinants. These results suggest that there is little correlation between the biofilm-forming ability and antimicrobial susceptibility in A. baumannii isolates. In addition, the emergence of MDR A. baumannii clinical isolates is generally caused by mutations of the genes associated with antimicrobial resistance and/or the acquisition of various antimicrobial resistance determinants.
참고문헌 (24)
- Van Looveren M, "Antimicrobial resistance of Acinetobacter spp. in Europe", Clin Microbiol Infect, 10, pp.684~704 (2004)[DOI]
- Richet HM, "Building communication networks: international network for the study and prevention of emerging antimicrobial resistance", Emerg Infect Dis, 7, pp.319~322 (2001)[DOI]
- Poirel L, "Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology", Clin Microbiol Infect, 12, pp.826~836 (2006)[DOI]
- Cho YJ, "Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals", Diagn Microbiol Infect Dis, 64, pp.185~190 (2009)[DOI]
- Hidalgo L, "Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK", J Antimicrob Chemother, 68, pp.1543~1550 (2013)[DOI]
- Cattoir V, "Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates", J Antimicrob Chemother, 60, pp.394~397 (2007)[DOI]
- Hujer KM, "Rapid determination of quinolone resistance in Acinetobacter spp", J Clin Microbiol, 47, pp.1436~1442 (2009)[DOI]
- Rodriguez-Bano J, "Biofilm formation in Acinetobacter baumannii: associated features and clinical implications", Clin Microbiol Infect, 14, pp.276~278 (2008)[DOI]
- Duarte A, "Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilm-forming ability", Comp Immunol Microbiol Infect Dis, 45, pp.29~33 (2016)[DOI]
- Longo F, "Biofilm formation in Acinetobacter baumannii", New Microbiol, 37, pp.119~127 (2014)
- Varga ZG, "Inhibition of quorum sensing and efflux pump system by trifluoromethyl ketone proton pump inhibitors", In Vivo, 26, pp.277~285 (2012)
- Vijay G, "Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species", Microbiology, 155, pp.2333~2341 (2009)[DOI]
- Marti S, "Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species", BMC Res Notes, 11, pp.4~5 (2011)
- 성지연, "대전지역 소재 대학병원에 blaOXA-23 유전자를 가지고 있는 다제내성 Acinetobacter baumannii의 확산", 대한임상검사과학회지, 48(2), pp.94~101 (2016), 대한임상검사과학회
- Bou G, "PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii", Clin Microbiol Infect, 6, pp.635~643 (2000)[DOI]
- Luo TL, "Association of blaOXA-23 and bap with the persistence of Acinetobacter baumannii within a major healthcare system", Front Microbiol, 12, pp.182~ (2015)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; twenty first informational supplement. M100-S21", CLSI, ~ (2011)
- Mak JK, "Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii", J Antimicrob Chemother, 63, pp.47~54 (2009)[DOI]
- Omid A, "Molecular analysis and expression of bap gene in biofilm-forming multi-drug-resistant Acinetobacter baumannii", Rep Biochem Mol Biol, 5, pp.62~72 (2016)
- Woodford N, "Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp", Int J Antimicrob Agents, 27, pp.351~353 (2006)[DOI]
- Thummeepak R, "Distribution of virulence genes involved in biofilm formation in multi-drug resistant Acinetobacter baumannii clinical isolates", Int Microbiol, 19, pp.121~129 (2016)
- Lihua Qi, "Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii", Front Microbiol, 7, pp.483~ (2016)
- Abidi SH, "Drug resistance profile and biofilm forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan", BMC Ophthalmol, 13, pp.57~ (2013)[DOI]
- Rao RS, "Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii", Indian J Med Microbiol, 26, pp.333~337 (2008)[DOI]